HASHIMOTO Keitaro | Department of Phamacology, Yamanashi Medical University
スポンサーリンク
概要
関連著者
-
HASHIMOTO Keitaro
Department of Pharmacology, Interdisciplinary Graduate School of Medicine and Engineering, Universit
-
Sugiyama Atsushi
Department of Pharmacology, School of Medicine, Toho University, Japan
-
Satoh Y
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Takahara Akira
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
-
Satoh Yoshioki
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Satoh Yoshioki
Department of Pharmacology, Yamanashi Medical University
-
Zhu Bing-mei
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Imai Shoichi
Department Of Phamacology Niigata University School Of Medicine
-
Nakamura Yuji
Department of Pharmacology, School of Medicine, Toho University, Japan
-
Nakamura Yuji
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
MIYAMOTO Shigeki
Department of Pharmacology, Yamanashi Medical University
-
Matsumaga Sigeki
Department Of Aquatic Bioscience Graduate School Of Agricultural And Life Sciences University Of Tok
-
Miyamoto Shigeki
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Ishida Yuko
Department of Forensic Medicine, Wakayama Medical University
-
HAGIHARA Atsushi
Department of Pathology, Osaka City University Medical School
-
Hagihara Atsushi
Department Of Pharmacology Yamanashi Medical University
-
IMAI Shoichi
Department of Pharmacology, Niigata University School of Medicine
-
TAKAHARA Akira
Pharmaceutical Research Laboratories, Ajinomoto Co., Inc.
-
Ishida Yuko
Department Of Pharmacology Yamanashi Medical University
-
Ishida Yuko
Department Of Forensic Medicine Wakayama Medical University
-
Tamura K
The Second Department Of Internal Medicine Yamanashi Medical University
-
Tamura Kohji
The 1st. Depertment Of Internal Medicine Niigata University School Of Medicine.
-
矢冨 裕
Department Of Clinical Laboratory The University Of Tokyo Hospital
-
Yatomi Yutaka
山梨大学 医学部臨床検査医学
-
Yatomi Yutaka
Department Of Pharmacology University Of Yamanashi Faculty Of Medicine
-
Yatomi Yutaka
山梨大学 薬理
-
Xue Yi
Department Of Pathology Yamanashi Medical University
-
矢冨 裕
山梨医科大学臨床検査医学
-
矢冨 裕
山梨医科大学 医学部 臨床検査医学講座
-
Xue Yi
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Yatomi Yutaka
Department Of Clinical Laboratory Medicine Graduate School Of Medicine The University Of Tokyo
-
Tamura Kohji
Second department of Medicine, Yamanashi Medical School
-
TAMURA Kohji
2nd Department of Internal Medicine, Yamanashi Medical College
-
Tamura Kohji
The Second Department of Internal Medicine, Yamanashi Medical University
-
AYE Nu
Department of Pharmacology, Yamanashi Medical University
-
Tsujimoto Gozoh
Department Of Genomic Drug Discovery Science Graduate School Of Pharmaceutical Sciences Kyoto Univer
-
Yatomi Yutaka
Department Of Laboratory Medicine Graduate School Of Medicine University Of Tokyo
-
Aye Nu
Department Of Pharmacology Yamanashi Medical University
-
Akie Yasuki
Fuji Biomedix Co. Ltd.
-
Awaji Takeo
Department Of Molecular Cell Pharmacology National Children 's Medical Research Center
-
Tamura Kohji
1st. Department Of Med. Niigata University
-
Kugiyama Kiyotaka
Second Department of Internal Medicine, Yamanashi University School of Medicine
-
YOSHIDA Hiroshi
Second Department of Medicine, Kurume University School of Medicine
-
Horii Ikuo
Showa Univ. (department Of Biochemical Toxicology School Of Pharmaceutical Sciences)
-
Horii I
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Horii Ikuo
Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Abe Junko
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Ando Kentaro
Department of Comparative Pathophysiology, Graduate School of Agricultural and Life Sciences, The Un
-
Akie Yasuki
Department of Pharmacology, School of Medicine, Toho University, Japan
-
Lurie Keith
Cardiac Arrhythmia Center Department Of Medicine University Of Minnesota
-
Ando Kentaro
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Ohta Masanori
Department Of Health Development Institute Of Industrial Ecological Sciences University Of Occupatio
-
Shiina Hiroyuki
Department Of Pharmacology Toho University Faculty Of Pharmaceutical Sciences
-
Shimada Hideaki
Department Of Gastroenterological Surgery Chiba Cancer Center
-
SUGITA Masao
Department of Neurosurgery, University of Yamanashi Faculty of Medicine
-
Hashimoto Toyozo
Department of Cardiology, Jichi Medical School
-
WANG Kai
Department of Pharmacology, Interdisciplinary Graduate School of Medicine and Engineering, Universit
-
Inoue Kiyoshi
Cardiovascular Disease Center, Tokyo Metropolitan Police Hospital
-
Wang Kai
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Wang Kai
Department Of Electric And Electronic Engineering Graduate School Of Engineering Miyazaki University
-
Noda Yoshiaki
Department Of Internal Medicine Yamanashi Central Hospital
-
CHINO Daisuke
Department of Pharmacology and Pharmacotherapy, School of Medicinal Pharmaceutical Sciences, Nihon P
-
Yamada Hiroshi
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Shimada H
Kumamoto Univ. Kumamoto
-
Shimada Hideaki
Department Of Pharmacology Toho University Faculty Of Pharmaceutical Science
-
HARUNO Akihiro
Department of Phamacology, Yamanashi Medical University
-
XUE Yixue
Department of Phamacology, Yamanashi Medical University
-
DOHMOTO Hideki
Pharmaceutical Research Laboratories, Ajinomoto Co., Inc.
-
YOSHIMOTO Ryota
Pharmaceutical Research Laboratories, Ajinomoto Co., Inc.
-
Eto Koji
Department Of Medicine (cardiology) Teikyo University School Of Medicine
-
Eto Koji
Department Chemistry & Biochemistry Graduate School Of Engineering Kyushu University
-
Horii Ikuo
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
AKIE Yasuki
Fuji Biomedix, Co., Ltd.
-
YAMADA Chikaomi
Department of Pharmacology, Interdisciplinary Graduate School of Medicine and Engineering, Universit
-
Yamada Chikaomi
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Kugiyama Kiyotaka
Second Department Of Internal Medicine Interdisciplinary Graduate School Of Medicine And Engineering
-
Kugiyama Kiyotaka
Second Department Of Internal Medicine Yamanashi Medical University
-
Ohyama Kenji
Department Of Clinical Nursing Yamanashi Medical University
-
Hirasawa Akira
Department Of Biophysics And Biochemistry Graduate School Of Science The University Of Tokyo
-
Akie Yasuki
Department Of Pharmacology Yamanashi Medical University
-
Tamura Kohji
The Second Department Of Internal Medicine Yamanashi Medical College
-
Sugita Masao
Department Of Neurosurgery University Of Yamanashi Faculty Of Medicine
-
Sugita Masao
Istec-srl
-
OZAKI Yukio
Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi
-
Nakamura Hideki
Department of Cardiovascular Medicine, Abashiri Kohsei General Hospital
-
YOSHIDA Hiroshi
Department of Clinical Laboratory Medicine, Fukushima Medical College
-
Nakazawa Mikio
Department of Medical Technology, School of Health Sciences, Faculty of Medicine, Niigata University
-
Shimada Hideaki
Department of Tissue and Organ Development, Regeneration and Advanced Medical Science, Gifu Universi
-
Motomura Shigeru
Department of Pharmacology, Hirosaki University Graduate School of Medicine
-
YAMAGUCHI Toshiaki
Department of Applied Chemistry, Graduate School of Engineering, Nagoya University
-
Yamaguchi T
Department Of Anesthesiology Yamanashi Medical University
-
Yamaguchi Toshiaki
山梨医科大学 麻酔科
-
Iwasaki Hiroshi
Department of Pathology, Faculty of Medicine, Fukuoka University
-
KITO Go
Shin Nippon Biomedical Laboratories (SNBL), Ltd.
-
HORII Ikuo
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
Nakajima Tamio
First Department Of Internal Medicine Nara Medical University
-
Xue Yi
Department Of Pharmacology Yamanashi Medical University
-
Nouchi Hideaki
Department Of Pharmacology Toho University Faculty Of Pharmaceutical Sciences
-
KUMAZAWA TERUO
Department of Anesthesia, Tokyo Medical and Dental University
-
TAMURA Takeshi
Department of Internal Medicine School of Medicine, Keio University
-
Ohyama Kenji
Interdisciplinary Graduate School of Medical and Engineering Sciences, University of Yamanashi
-
Shimada Hideaki
千葉大学 医学研究院先端応用外科学
-
Shimada H
Department Of Frontier Surgery Graduate School Of Medicine Chiba University
-
Yamazaki Kiyoyuki
Department Of Bio-medical Engineering Tokai University
-
Kumazawa Teruo
山梨医科大学 麻
-
Kumazawa Teruo
Department Of Anesthesia Tokyo Medical And Dental University
-
Kumazawa Teruo
Department Of Anesthesia Yamanashi Medical College
-
Hirasawa Akira
Department Of Gynecology Keio University Hospital
-
Tanaka Toshikazu
Department of Cardiology, Okazaki City Hospital
-
Harada Ken-ichi
Department Of Human Pathology Kanazawa University Graduate School Of Medicine
-
TANAKA Hikaru
Department of Pharmacology, Toho University School of
-
SHIGENOBU Koki
Department of Pharmacology, Toho University School of
-
HAMADA Yoshimasa
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
-
SHIOTANI Motohiro
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan
-
HARADA Takuma
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan
-
ABE Junko
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan
-
SAWADA Yasufusa
Pharmacokinetics Dynamics Metabolism, Pfizer Global Research and Development, Nagoya Laboratories, P
-
Iwasaki Hiroshi
Department Of Anesthesiology And Critical Care Medicine Asahikawa Medical College
-
Ohyama K
Department Of Pediatrics Yamanashi Medical University
-
Ohyama Kenji
Department Of Pediatrics Faculty Of Medicine University Of Yamanashi
-
Fujimura Akio
Department Of Clinical Pharmacology Jichi Medical School
-
Tanaka Hikaru
Dep. Of Pharmacology Toho Univ. Fac. Of Pharmaceutical Sciences Jpn
-
Tanaka H
Department Of Pharmacology Toho University School Of Pharmaceutical Sciences
-
Ohta Masanori
Interdisciplinary Graduate School Of Medical And Engineering Sciences Univ. Of Yamanashi
-
Ohta M
Department Of Pediatrics Faculty Of Medicine University Of Yamanashi
-
Ohta Masanori
Department Of Health Development University Of Occupational And Environmental Health
-
Takeda Kentaro
Department Of Pharmacology Toho University Faculty Of Pharmaceutical Sciences
-
Shigenobu K
Department Of Pharmacology Toho University Faculty Of Pharmaceutical Sciences
-
Shigenobu K
Department Of Pharmacology Toho University School Of Pharmaceutical Sciences
-
Shigenobu Koki
Department Of Chemical Pharmacology Faculty Of Pharmaceutical Sciences The University Of Tokyo
-
Nakaya Haruaki
Department Of Orthopaedic Surgery And Pharmacology School Of Medicine Chiba University
-
Ueno Akira
Department of Internal Medicine, Division of Cardiology, Nippon Medical School
-
Tsuruoka Noriko
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
-
TAMURA Miku
Department of Pharmacology, Toho University Faculty of Pharmaceutical Sciences
-
Shimazaki Shuji
Department of Emergency Medicine, Kyorin University School of Medicine
-
Noda Y
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Tanaka Toshikazu
Department Of Anatomy Faculty Of Medicine Kyoto University
-
AOKI Shigeki
Department of Radiology, The University of Tokyo Hospital
-
Kito Go
新日本科学
-
Hirasawa A
Ajinomoto Co. Inc. Kawasaki Jpn
-
Hirasawa Akira
Pharmaceutical Research Laboratories Ajinomoto Co. Inc.
-
Tanaka Hikaru
Dep. Of Pharmacology Fac. Of Pharmaceutical Sciences Toho Univ.
-
Tanaka Hikaru
Department Of Pharmacology Toho University Faculty Of Pharmaceutical Sciences
-
KASHIMOTO Satoshi
Department of Anesthesiology, Faculty of Medicine, University of Yamanashi,
-
AWAJI Takeo
Department of Phamacology, Yamanashi Medical University
-
WU Zhenjiu
Department of Phamacology, Yamanashi Medical University
-
SHOJI Masataka
Pharmaceutical Research Laboratories, Ajinomoto Co., Inc.
-
KATO Kiyohiko
Department of Materials Science, Faculty of Engineering, Kitami Institute of Technology
-
Shigenobu Koki
Toho University School Of Pharmaceutical Sciences
-
Shiina Hiroyuki
Second Department of Internal Medicine, Shinshu University, School of Medicine
-
Eto K
Yamaguchi Medical Univ. Yamaguchi Jpn
-
Eto Koji
Department Of Pharmacology Yamanashi University
-
Komori Sadayoshi
Department of Second Internal Medicine, Yamanashi Medical University
-
HAMADA YOSHIMASA
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
HORII IKUO
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
OHMORI Masami
Department of Clinical Pharmacology, Jichi Medical School
-
SHIOTANI Motohiro
Toxicology, Worldwide Safety Sciences, Global Research & Development, Pfizer Japan Inc.
-
HARADA Takuma
Toxicology, Worldwide Safety Sciences, Global Research & Development, Pfizer Japan Inc.
-
ABE Junko
Toxicology, Worldwide Safety Sciences, Global Research & Development, Pfizer Japan Inc.
-
OGUCHI TAKESHI
Department of Anesthesiology, Yamanashi Medical University
-
KANDA Minoru
Department of Urology, Kanbara General Hospitali
-
TANABE Nobuaki
Department of Urology, University of Yamanashi
-
ZHU Bing
Department of Pharmacology, Yamanashi Medical University
-
KOBAYASHI MAKIO
Second Department of Pathology, Yamanashi Medical College
-
KAWAMURA Tomokazu
the Second Department of Internal Medicine
-
Motomura Shigeru
Department Of Pharmacology Hirosaki University
-
Kawamura Tomokazu
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Kito Go
Shin Nippon Biomedical Laboratories (snbl) Ltd
-
HORII Ikuo
Nippon Roche Research Center
-
HAMADA Taiji
Shin Nippon Biomedical Laboratories (SNBL), Ltd
-
JIKUZONO Tatsuya
Shin Nippon Biomedical Laboratories (SNBL), Ltd
-
KOBAYASHI Kazuko
Nippon Roche Research Center
-
Ozaki Yukio
Department Of Cardiology Aichi Medical University
-
Ozaki Yukio
Department Of Laboratory Medicine Yamanashi Medical University
-
Shimada Hideaki
Department Of Frontier Surgery Chiba University Graduate School Of Medicine
-
Shimada Hideaki
Department Of Academic Surgery Graduate School Of Medicine Chiba University
-
Iwasaki Hiroshi
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Tanaka Toshikazu
Department Of Pharmacology Toho University Faculty Of Pharmaceutical Sciences
-
SAWA Yoshio
Department of Applied Physics, Tokai University
-
Ohyama Kenji
山梨大学 医学部小児科学教室
-
SAWADA Norifumi
Department of Urology, Yamanashi Kousei Hospital
-
Takasuna Kiyoshi
New Product Research Laboratories Ii Daiichi Pharmaceutical Co. Ltd.
-
Zhu Bing-mei
Department Of Pharmacology Yamanashi Medical University
-
Zhu Bing
Department Of Electronic Engineering School Of Engineering The University Of Tokyo
-
Shen Hua
Department Of Biochemistry Interdisciplinary Graduate School Of Medicine And Engineering University
-
Xue Y
Yamanashi Medical Univ. Yamanashi
-
Wu Zhenjiu
Department Of Phamacology Yamanashi Medical University
-
Kumazawa T
Yamanashi Medical Univ. Yamanashi Jpn
-
Mori Toyoki
Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.
-
Awaji T
National Children's Medical Res. Center Tokyo Jpn
-
Awaji Takeo
Department Of Pharmacology Yamanashi Medical College
-
Tamura Miku
大妻女子大学 食物学科
-
Tamura Miku
Department Of Pharmacology Toho University Faculty Of Pharmaceutical Sciences
-
Kanda Minoru
Department Of Urology
-
Hamada Taiji
Shin Nippon Biomedical Laboratories (snbl) Ltd
-
Sawada Norifumi
Department Of Pharmacology Yamanashi Medical University
-
Tsujimoto G
Department Of Molecular Cell Pharmacology National Children's Medical Research Center
-
Kanai Naoaki
Department Of Bio-medical Engineering School Of High-technology For Human Welfare Tokai University
-
Tsurugi Kunio
Department Of Biochemistry Interdisciplinary Graduate School Of Medicine And Engineering University
-
Tsurugi Kunio
Department Of Biochemistry 2 University Of Yamanashi Faculty Of Medicine
著作論文
- PRACTICAL APPLICATION OF GUINEA PIG TELEMETRY SYSTEM FOR QT EVALUATION
- Comparison of Four Rate-Correction Algorisms for the Ventricular Repolarization Period in Assessing Net Effects of I_ Blockers in Dogs
- Analysis of Arrhythmogenic Profile in a Canine Model of Chronic Atrioventricular Block by Comparing In Vitro Effects of the Class III Antiarrhythmic Drug Nifekalant on the Ventricular Action Potential Indices Between Normal Heart and Atrioventricular Bloc
- Effect of the New Class III Antiarrhythmic Drug MS-551 and d-Sotalol on Canine Coronary Ligation-Reperfusion Ventricular Arrhythmias
- In Vivo Antiarrhythmic Profile of AP-792 Assessed in Different Canine Arrhythmia Models
- Comparison of the Electropharmacological Effects of Verapamil and Propranolol in the Halothane-Anesthetized In Vivo Canine Model Under Monophasic Action Potential Monitoring
- Pravastatin Prevents Arrhythmias Induced by Coronary Artery Ischemia/Reperfusion in Anesthetized Normocholesterolemic Rats
- P6-14 Development of telemetry system for QT evaluation in guinea pigs(LIVER AND DIGESTIVE SYSTEM/CIRCULATORY SYSTEM-1/DEVELOPMENT AND REPRODUCTION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Effects of Intravenous Anesthetics on Function and Metabolism in the Reperfused Working Rat Heart
- Constitutional Rho-Kinase Regulates the Electrophysiological and Mechanical Function of the Heart Besides the Coronary Vascular Tone
- Cardiac Effects of a Selective Rho-Associated Kinase Inhibitor, Y-27632, Assessed in Canine Isolated, Blood-Perfused Heart Preparations
- Effects of Sphingosine 1-Phosphate, a Naturally Occurring Biologically Active Lysophospholipid, on the Rat Cardiovascular System
- Antiarrhythmic and Proarrhythmic Effects of Sematilide in Canine Ventricular Arrhythmia Models
- Effects of KB-R9032, a new Na^+/H^+ Exchange Inhibitor, on Canine Coronary Occlusion/Reperfusion-Induced Ventricular Arrhythmias
- Block of Na exchangers on ischemia induced arrhythmias
- DEVELOPMENT OF TELEMETRY SYSTEM IN THE COMMON MARMOSET : CARDIOVASCULAR EFFECTS OF ASTEMIZOLE AND NICARDIPINE
- 0453 INHIBITION OF Na^+/H^+ EXCHANGE SUPPRESSES BOTH REBOUND RECOVERY OF MYOCARDIAL CREATINE PHOSPHATE (Cr-P) AND LETHAL ARRHYTHMIAS DURING REPERFUSION AFTER A BRIEF ISCHEMIA
- OJ-006 Comparison of Electropharmacological Effects of Sotalol and Bepridil Assessed in the in Vivo Canine Heart(Cardiovascular pharmacology, basic/clinical-2 (H) OJ1,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japan
- P400 CAN THE MAP TECHNIQUE BE APPLIED TO DETECT DELAYED AFTERDEPOLARIZATION ? : ELECTROPHYSIOLOGICAL AND PHARMACOLOGICAL EVIDENCE
- 0901 EFFECT OF A CLASS III ANTIARRHYTHMIC DRUG ON REFRATORY PERIOD. : DEMONSTRATION OF REVERSE USE DEPENDENCY ASSESSED BY MONOPHASIC ACTION POTENTIALS.
- -P159- Effects of Sodium and Calcium Channel Blockers on Monophasic Action Potential(MAP)Recordings Assessed by the Canine Isolated, Blood-Perfused Ventricular Tissue Preparation(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATIO
- -P157- Electrophysiological and Pharmacological Characteristics of Digitalis-induced Triggered Activity in the Canine Isolated, Blood-perfused Ventricular Muscle Preparation.(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SO
- Effect of the Sarcolemmal K_ Channel Blocker HMR1098 on Arrhythmias Induced by Programmed Electrical Stimulation in Canine Old Myocardial Infarction Model : Comparison With Glibenclamide
- KB-R7943, a Na^+/Ca^ Exchange Inhibitor, Does Not Suppress Ischemai/Reperfusion Arrhythmias nor Digitalis Arrhythmias in Dogs
- Inhibitory Effects of Pre-ischemic and Post-ischemic Treatment With FR 168888, a Na^+/H^+ Exchange Inhibitor, on Reperfusion-Induced Ventricular Arrhythmias in Anesthetized Rat
- Slowing Na^+ Channel Inactivation Prolongs QT Interval and Aggravates Adrenaline-Induced Arrhythmias
- A Red Wine Vinegar Beverage can Inhibit the Renin-Angiotensin System : Experimental Evidence in Vivo(Pharmacology)
- The Endothelium-Dependent Vasodilator Action of a New Beverage Made of Red Wine Vinegar and Grape Juice(Pharmacology)
- Dangerous QT Prolongation Can be Assayed with Two Types of In Vivo Models ; Halothane-Anesthetized Dog and Chronic Atrioventricular Block Dog(Cardiovascular Pharmacology, Basic/Clinical 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation
- The Antipsychotic and Antiemetic Drug Prochlorperazine Delays the Ventricular Repolarization of the In Situ Canine Heart
- Electropharmacological Effects of a Spironolactone Derivative, Potassium Canrenoate, Assessed in the Halothane-Anesthetized Canine Model
- Cardiovascular Effects of an L/N-type Ca^ Channel Blocker Cilnidipine Assessed in the Chronic Atrioventricular Conduction Block Dogs
- PE-353 Mexiletine Decreased the Ventricular Electrical Vulnerability in the Canine Model of Sparfloxacin-Induced Long QT Syndrome(Cardiovascular Pharmacology, Basic/Clinical 3 (H) : PE60)(Poster Session (English))
- OE-275 A Spironolactone Derivative, Potassium Canrenoate, Prolongs the QT Interval but Shortens the Electrically Vulnerable Period of In Vivo Canine Hearts(Cardiovascular Pharmacology, Basic/Clinical 1 (H) : OE34)(Oral Presentation (English))
- The QT-Prolonging Effects of a Histamine H1 Receptor Antagonist Terfenadine Assessed in the In Vivo Canine Heart Model: Comparison of the Rate-Correcting Methods for the Ventricular Repolarization Periods
- Relationship Between Phosphodiesterase Inhibition Induced by Several Kampo Medicines and Smooth Muscle Relaxation of Gastrointestinal Tract Tissues of Rats
- N- Plus L-Type Ca^ Channel Blocker Cilnidipine Decreased the Proarrhythmic Potential of the Canine Sudden Cardiac Death Model
- Effects of Clinically Available Blended Herbal Medicines (Kampo Extracts) on the Phosphodiesterase Activity in Rat Hearts
- Cardiovascular and Adenylate Cyclase Stimulating Effects of Colforsin Daropate, a Water-Soluble Forskolin Derivative, Compared With Those of Isoproterenol, Dopamine and Dobutamine
- Effects of Disopyramide and Mexiletine on the Terminal Repolarization Process of the In Situ Heart Assessed Using the Halothane-Anesthetized In Vivo Canine Model
- Comparison of the In Vivo Electrophysiological and Proarrhythmic Effects of Amiodarone With Those of a Selective Class III Drug, Sematilide, Using a Canine Chronic Atrioventricular Block Model
- Effects of a Novel Vesamicol Receptor Ligand, m-(Iodobenzyl)trozamicol, on the Canine Isolated, Blood-Perfused Atrioventricular Node Preparation
- -0933- Measurement of Adenylyl Cyclase Activity in the Contractile and Conductive Elements of the Canine Heart : Comparison of the Regional Adenylyl Cyclase Activity after the Treatment by Purinergic or Cholinergic Agonists.(PROCEEDINGS OF THE 59th ANNUAL
- Development of a Halothane-Adrenaline Arrhythmia Model Using In Vivo Guinea Pigs
- 一次救命のための新たな携帯型人工呼吸器の開発
- Quantitative Analysis of the Antiarrhythmic Effect of Drugs on Canine Ventricular Arrhythmias by the Determination of Minimum Effective Plasma Concentrations : Pharmacology and Clinical Evaluation of Antiarrhythmic Drugs
- PERIPHERAL EFFECTS OF GUANFACINE COMPARED TO THOSE OF CLONIDINE THE DOG
- Pharmacological and Electrophysiological Characterization of Junctional Rhythm During Radiofrequency Catheter Ablation of the Atrioventricular Node : Possible Involvement of Neurotransmitters From Autonomic Nervous System
- Electrophysiological, Anatomical and Histological Remodeling of the Heart to AV Block Enhances Susceptibility to Arrhythmogenic Effects of QT-Prolonging Drugs
- Molecular Mechanisms of Cardiostimulatory Effects of Sildenafil
- Effects of Sildenafil (Viagra TM) on the Cyclic AMP Hydrolyzing Phosphodiesterase Activity in the Canine Heart Assessed Using a Modified Enzymatic Fluorometric Assay Technique
- Effects of ONO : 2235, an Aldose Reductase Inhibitor, on Muscarinic Receptors and Contractile Response of the Urinary Bladder in Rats with Streptozotocin : Induced Diabetes
- Physical and Pharmacological Regulation of Atrial Natriuretic Peptide Release from the Isolated, Blood-Perfused Right Atrium of the Dog
- Clinical Study of Delapril Hydrochloride in Patients with Acute Myocardial Infarction: Effects of Early ACE Inhibition foflowing Effective Thrombofytic Coronary Recanalizati
- Effects of Mexiletine on the Canine Cardiovascular System Complicating Cisapride Overdose: Potential Utility of Mexiletine for the Treatment of Drug-Induced Long QT Syndrome
- Effect of Magnesium Sulfate on the Haloperidol-Induced QT Prolongation Assessed in the Canine In Vivo Model Under the Monitoring of Monophasic Action Potential
- Effects of a Class III Antiarrhythmic Drug, Dofetilide, on the In Situ Canine Heart Assessed by the Simultaneous Monitoring of Hemodynamic and Electrophysiological Parameters
- Cardiac Effects of Clinically Available Kampo Medicine Assessed With Canine Isolated, Blood-Perfused Heart Preparations
- EFFECTS OF PROSTAGLANDINS ON LATE CORONARY LIGATION ARRHYTHMIAS IN THE DOG
- Characterization of the Halothane-Anesthetized Guinea-Pig Heart as a Model to Detect the K^+ Channel Blocker-Induced QT-Interval Prolongation(Pharmacology)
- PJ-719 Beat-to-beat Variability of Ventricular Repolarization Period Can Predict Onset of Acquired Long QT Syndrome(Arrhythmia, basic-6 (A) PJ121,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-345 Long-term Blockade of N-type Ca^ Channels Reversed the Ventricular Electrical Remodeling in the Canine Model of Long QT Syndrome(Cardiovascular pharmacology, basic/clinical-4 (H) PJ58,Poster Session (Japanese),The 70th Anniversary Annual Scient
- Halothane Sensitizes the Guinea-Pig Heart to Pharmacological I_ Blockade : Comparison With Urethane Anesthesia
- A Simple In Vivo Atrial Fibrillation Model of Rat Induced by Transesophageal Atrial Burst Pacing
- ON THE HISTAMINE RECEPTOR OF THE CANINE MYOCARDIUM AND CORONARY VASCULATURE
- CARDIAC EFFECTS OF A NEW POSITIVE INOTROPIC AGENT, OPC-8212, UNDER INFLUENCE OF DIGITALIS : Heart Failure, Cardiotonic Drugs : FREE COMMUNICATIONS (V) : PROCEEDINGS OF THE 49th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- Cardiac Effects of Salvia Miltiorrhiza/Dalbergia Odorifera Mixture, an Intravenously Applicable Chinese Medicine Widely Used for Patients With Ischemic Heart Disease in China
- Antiarrhythmic Effects of Possible Anti-Ischemic Drugs
- Effects of Six Beta Blocking Agents on Cardiovascular Responses during Exercise
- EFFECTS OF FTORAFUR AND 5-FLUOROURACIL ON THE CANINE SINOATRIAL NODE
- Effects of Lidocaine and Procaine on the Action Potential of Canine Sinus Nodal Cells
- Effect of New Type β-blocker, Tilisolol Hydrochloride,on the Cardiovascular System in Healthy Young Volunteers
- Do Antiarrhythmic Drugs Act on the Site of Abnormal Impulse Generation or Act on the Normal Myocardium? : SYMPOSIUM ON VENTRICULAR ARRHYTHMIA : BASIC AND CLINICAL STUDIES : 50th Annual Scientific Session of the Japanese Circulation Society
- Pravastatin Inhibits Arrhythmias Induced by Coronary Artery Ischemia in Anesthetized Rats
- Antiarrhythmic Properties of a Prior Oral Loading of Amiodarone in In Vivo Canine Coronary Ligation/Reperfusion-Induced Arrhythmia Model : Comparison With Other Class III Antiarrhythmic Drugs
- Electrophysiologic Effects of an Antiarrhythmic Agent, Bidisomide, on Sodium Current in Isolated Rat Ventricular Myocytes: Comparison With Mexiletine and Disopyramide
- Cardiovascular Effects of L-158,809, a New Angiotensin Type 1 Receptor Antagonist, Assessed Using the Halothane-Anesthetized In Vivo Canine Model
- Acute Electropharmacological Effects of Intravenously Administered Amiodarone Assessed in the In Vivo Canine Model
- INHIBITORY EFFECT OF MORICIZINE ON REPERFUSION INDUCED TACHYARRHYTHMIAS IN RATS : A Comparison Study with Disopyramide and Mexiletine
- THE EFFECT OF PRETREATMENT WITH MORICIZINE ON EARLY ARRHYTHMIA RESULTING FROM MYOCARDIAL ISCHEMIA IN RATS
- Antiarrhythmic Effects of Bisaramil on Triggered Arrhythmias Produced by Intracoronary Injection of Digitalis and Adrenaline in the Dog
- Pharmacological Evaluation of a New Laser Blood Flowmeter for Measuring Coronary Blood Flow, Assessed in the Canine Isolated, Blood-Perfused Ventricular Tissue Preparation in Comparison With an Electromagnetic Flowmeter
- Utilization of Telemetry System to Assess the Cardiovascular Profile of AH-1058, a New Cardioselective Ca^ Channel Blocker, in Conscious Dogs
- -42- THE PROPERTIES OF "IN VIVO" TRIGGERED ACTIVITY INDUCED BY ADRENALINE OR OUABAIN : Arrhythmias : FREE COMMUNICATIONS(I) : PROCEEDINGS OF THE 51th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- QT PRODACT : Database Construction for the Evaluation of the Risk of QT Interval Prolongation by Drugs in Japan
- ANTIARRHYTHMIC EFFECT OF OXPRENOLOL ON HALOTHANE-EPINEPHRINE AND CORONARY LIGATION INDUCED VENTRICULAR ARRHYTHMIAS IN BEAGLE DOGS
- Hypotensive and Vascular Effects of Labetalol in the Normotensive Rat and Dog
- Acute Hypokalemia May Not Be an Effective Way to Sensitize the In Situ Canine Heart for Sparfloxacin-Induced Long QT Syndrome
- Topics on the Na^+/Ca^ Exchanger : Involvement of Na^+/Ca^ Exchange System in Cardiac Triggered Activity
- Topics on the Na+/Ca2+ Exchanger: Involvement of Na+/Ca2+ Exchange System in Cardiac Triggered Activity
- Preclinical evaluation of QT prolonging drugs(SEMINAR 1 : MODELS FOR PROFILING THE POTENTIAL QTc PROLONGATION RISK OF A DRUG (ICH-57B)ICH SAFETY FORUM 2002)
- Development of a Halothane-Adrenaline Arrhythmia Model Using In Vivo Guinea Pigs
- EL-6 QT prolongation and arrhythmia(EDUCATIONAL LECTURE)(Proceedings of the 31st Annual Meeting)
- Release of atrial natriuretic peptide from the isolated, blood-perfused right atrium of the dog.
- Histamine H2-receptor mediated positive dromotropic effect in the canine atrioventricular node.
- Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: Comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedipine and n
- The first demonstration of CGRP-immunoreactive fibers in canine hearts: Coronary vasodilator, inotropic and chronotropic effects of CGRP in canine isolated, blood-perfused heart preparations.
- Effects of OPC-18790, a New Positive Inotropic Agent, on Canine Ventricular Arrhythmias.
- Developmental alteration in adrenergic regulation of hepatic glycogen phosphorylase.
- Effect of cibenzoline, a class I antiarrhythmic drug, on action potential in canine ventricular muscle.
- Effects of betaxolol, a new beta 1 selective blocker, on canine ventricular arrhythmias.
- Antiarrhythmic effects of a new drug, E-0747, on canine ventricular arrhythmia models.
- Effects of lidocaine, disopyramide and verapamil on the in vivo triggered ventricular arrhythmia in digitalized canine heart.
- Antiarrhythmic effect of a new class 1 antiarrhythmic drug, nicainoprol, on canine ventricular arrhythmias.
- Antiarrhythmic profile of a new class 1 drug, AHR 10718, on canine atrial and ventricular arrhythmia models.
- Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog.
- Comparison of Cardiovascular Effects of a Novel Class Ic Antiarrhythmic Agent, NIK-244, with Those of Flecainide in Isolated Canine Heart Preparations Cross-Circulated with a Donor Dog.
- Electrophysiological effects of procaine in rabbit sino-atrial node cells.
- Effects of a New Antiarrhythmic Drug, SD-3212, on Canine Ventricular Arrhythmia Models.
- Utilization of an Isolated, Blood-Perfused Canine Papillary Muscle Preparation as a Model to Assess Efficacy and Adversity of Class I Antiarrhythmic Drugs.
- Chronotropic and inotropic effects of Kampo extracts in the canine isolated, blood-perfused heart preparations.
- Antiarrhythmic effects of the class 1c antiarrhythmic drug, flecainide, on canine ventricular arrhythmia models.
- Antiarrhythmic plasma concentrations of pirmenol on canine ventricular arrhythmias.
- Antiarrhythmic effects of coronary vasodilators on canine ventricular arrhythmia models.
- Electrophysiological Mechanisms for Digitalis Arrhythmias : Symposium on Electrophysiological Basis for the Genesis and the Treatment of Arrhythmias